JML is a Canadian company based in Vancouver BC, specializing in custom synthesis of organic and biological molecules for research and nuclear medicine centers, universities and pharmaceutical companies. JML is a pioneer in developing precursors for the PET/SPECT centers and performing radio-labeling for customers. JML provides optimal synthesis, labeling and quality control, all performed by our highly experienced chemists. JML's team approach supports your research objectives and provides superior results. Design the most effective routes to solving your synthesis and radio labeling challenges, using JML's consultative approach.